PSMA-binding agents: versatile against prostate cancer

GSTDTAP > 资源环境科学

	PSMA-binding agents: versatile against prostate cancer
	admin
	2021-02-23
发布年	2021
语种	英语
国家	德国
领域	资源环境
正文(英文)	PSMA-binding agents specifically dock onto prostate cancer cells. Coupled to diagnostic or therapeutic radionuclides, they can improve the diagnosis and treatment of prostate cancer. Scientists from the DKTK partner site in Freiburg, together with scientists from the Max Planck Institute for Medical Research, have now used STED microscopy to investigate for the first time how these substances are taken up by the cell and distributed intracellularly. In addition, a first clinical application showed that hybrid PSMA-binding agents containing both a diagnostic radionuclide and a fluorescent dye are suitable for visualizing prostate cancer both before and during surgery.In the DKTK, the German Cancer Research Center (DKFZ) in Heidelberg, as the core center, joins forces in the long term with university partner sites in Germany that have a special reputation for oncology.
URL	查看原文
来源平台	Helmholtz Association
文献类型	新闻
条目标识符	http://119.78.100.173/C666/handle/2XK7JSWQ/316803
专题	资源环境科学
推荐引用方式 GB/T 7714	admin. PSMA-binding agents: versatile against prostate cancer. 2021.